NCT00719693已完成1 期
Assessment of the Effect of Food on ABT-143 Bioavailability
适应症
干预措施
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 115
- 试验地点
- 1
- 主要终点
- Pharmacokinetics
研究概览
简要总结
Single-dose, open-label, two-period crossover study of ABT-143
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 55 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •18-55 years of age (inclusive)
- •BMI 19 to 29 inclusive
排除标准
- •Asian ancestry
- •Concurrent participation in another study
- •Females pregnant or breastfeeding
研究组 & 干预措施
A
Experimental
ABT-143 under low-fat meal condition
干预措施: ABT-143 ( rosuvastatin calcium and fenofibric acid ) (Drug)
B
Experimental
ABT-143 under fasting meal condition
干预措施: ABT-143 (rosuvastatin calcium and fenofibric acid ) (Drug)
结局指标
主要结局
Pharmacokinetics
时间窗: 7 days
次要结局
- Adverse Events(30 days)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected SubjectsHCV InfectionNCT00696904AbbVie133
已完成
1 期
Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male SubjectsHealthyNCT02259985Boehringer Ingelheim15
已完成
1 期
A Food-Effect Study of BPI-16350 in Healthy SubjectsHealthyNCT05316259Betta Pharmaceuticals Co., Ltd.24
已完成
1 期
Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin CalciumAdverse EventsPharmacokineticNCT00681395AstraZeneca64
已完成
1 期
Study to Evaluate the Effect of Food on the Pharmacokinetics of a BGB-3111 in Healthy SubjectsHealthy VolunteersNCT04163523BeiGene18